China NMPA Inspection - Guilin Pharmaceutical Co., Ltd. - May 31, 2015
China NMPA unannounced inspection for Guilin Pharmaceutical Co., Ltd. published May 31, 2015. A regulatory announcement initiated an investigation into pharmaceutical manufacturers purchasing unauthorized ginkgo leaf extract from Guilin Xingda
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Guilin Pharmaceutical Co., Ltd. published May 31, 2015. A regulatory announcement initiated an investigation into pharmaceutical manufacturers purchasing unauthorized ginkgo leaf extract from Guilin Xingda
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: 11ce200c-1831-4eec-8040-a09e8803dca9
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox